...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >High risk of QT interval prolongation and torsades de pointes associated with intravenous quinidine used for treatment of resistant malaria or babesiosis
【24h】

High risk of QT interval prolongation and torsades de pointes associated with intravenous quinidine used for treatment of resistant malaria or babesiosis

机译:与静脉注射奎尼丁有关的耐药性疟疾或杆状杆菌病,存在QT间期延长和扭转性高发的高风险

获取原文
获取原文并翻译 | 示例
           

摘要

Cardiac toxicity may be associated with drugs used for malaria. Torsades de pointes (TdP) is a well-known adverse effect of quinidine when used for atrial fibrillation. Intravenous quinidine doses for resistant malaria are 2 to 3 times higher than those used for arrhythmias. Among 6 patients receiving quinidine for malaria or babesiosis, 4 developed QT interval prolongation and 2 experienced TdP. Clinicians should be aware that recommended doses of quinidine for malaria carry a high TdP risk.
机译:心脏毒性可能与用于疟疾的药物有关。尖端扭转型眼病(TsP)是奎尼丁用于房颤时的一种众所周知的不良反应。耐药性疟疾的静脉注射奎尼丁剂量比心律不齐使用剂量高2至3倍。在接受奎尼丁治疗的疟疾或杆状菌病的6例患者中,有4例出现QT间期延长,2例经历了TdP。临床医生应意识到,推荐的奎尼丁剂量用于疟疾具有很高的TdP风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号